JP2023514750A5 - - Google Patents
Info
- Publication number
- JP2023514750A5 JP2023514750A5 JP2022550891A JP2022550891A JP2023514750A5 JP 2023514750 A5 JP2023514750 A5 JP 2023514750A5 JP 2022550891 A JP2022550891 A JP 2022550891A JP 2022550891 A JP2022550891 A JP 2022550891A JP 2023514750 A5 JP2023514750 A5 JP 2023514750A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980700P | 2020-02-24 | 2020-02-24 | |
| US62/980,700 | 2020-02-24 | ||
| US202063053565P | 2020-07-17 | 2020-07-17 | |
| US63/053,565 | 2020-07-17 | ||
| PCT/US2021/019181 WO2021173523A1 (en) | 2020-02-24 | 2021-02-23 | Hot melt extruded solid dispersions containing a bcl2 inhibitor |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023514750A JP2023514750A (ja) | 2023-04-07 |
| JPWO2021173523A5 JPWO2021173523A5 (https=) | 2024-03-04 |
| JP2023514750A5 true JP2023514750A5 (https=) | 2024-03-04 |
| JP7849296B2 JP7849296B2 (ja) | 2026-04-21 |
Family
ID=74875347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550891A Active JP7849296B2 (ja) | 2020-02-24 | 2021-02-23 | Ｂｃｌ２阻害剤を含むホットメルト押出し固体分散体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230295183A1 (https=) |
| EP (1) | EP4110298A1 (https=) |
| JP (1) | JP7849296B2 (https=) |
| KR (1) | KR20220158725A (https=) |
| CN (1) | CN115484933B (https=) |
| AU (1) | AU2021228622A1 (https=) |
| CA (1) | CA3173041A1 (https=) |
| IL (1) | IL295803A (https=) |
| MX (1) | MX2022010410A (https=) |
| WO (1) | WO2021173523A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4442685A4 (en) | 2021-12-06 | 2025-11-19 | Hangzhou Healzen Therapeutics Co Ltd | BCL-2 PROTEIN ANTI-APOPTOTIC INHIBITOR: PHARMACEUTICAL COMPOSITION AND USES |
| US11964990B2 (en) | 2022-01-21 | 2024-04-23 | Abbvie Inc. | 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors |
| CN115894495B (zh) * | 2022-11-29 | 2024-08-09 | 大连理工大学 | 一种基于尿酸与苯硼酸衍生物复合晶体的纯有机室温磷光材料的制备方法 |
| CN116236583A (zh) * | 2023-03-30 | 2023-06-09 | 广州麓鹏制药有限公司 | 一种含Bcl-2/Bcl-xl抑制剂的组合物及其制备方法与应用 |
| CN116270660A (zh) * | 2023-03-30 | 2023-06-23 | 广州麓鹏制药有限公司 | 一种含Bcl-2/Bcl-xl抑制剂的组合物及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19913692A1 (de) | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| DE19929361A1 (de) | 1999-06-25 | 2001-01-04 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| WO2005049593A2 (en) | 2003-11-13 | 2005-06-02 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
| US7790190B2 (en) | 2004-03-20 | 2010-09-07 | Yasoo Health, Inc. | Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid |
| WO2008064116A2 (en) | 2006-11-16 | 2008-05-29 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| EP2231159A1 (en) | 2007-11-16 | 2010-09-29 | Abbott Laboratories | Method of treating arthritis |
| US20100297194A1 (en) * | 2009-04-30 | 2010-11-25 | Nathaniel Catron | Formulation for oral administration of apoptosis promoter |
| TWI540132B (zh) | 2009-06-08 | 2016-07-01 | 亞培公司 | Ｂｃｌ-２族群抑制劑之口服醫藥劑型 |
| UA113500C2 (xx) * | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| CA3152557A1 (en) | 2010-10-29 | 2012-05-03 | Abbvie Inc. | Solid dispersions containing an apoptosis-inducing agent |
| CN106232144B (zh) * | 2014-03-18 | 2019-12-06 | 武田药品工业株式会社 | 固体分散体 |
| WO2017132474A1 (en) * | 2016-01-30 | 2017-08-03 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| EP3333167A1 (en) * | 2016-12-09 | 2018-06-13 | LEK Pharmaceuticals d.d. | Solid forms of venetoclax |
| AU2018322059C1 (en) | 2017-08-23 | 2024-09-12 | Guangzhou Lupeng Pharmaceutical Company Ltd. | BCL-2 inhibitors |
| US12220419B2 (en) * | 2018-08-22 | 2025-02-11 | Newave Pharmaceutical Inc. | BCL-2 inhibitors |
-
2021
- 2021-02-23 KR KR1020227033262A patent/KR20220158725A/ko active Pending
- 2021-02-23 IL IL295803A patent/IL295803A/en unknown
- 2021-02-23 CA CA3173041A patent/CA3173041A1/en active Pending
- 2021-02-23 JP JP2022550891A patent/JP7849296B2/ja active Active
- 2021-02-23 AU AU2021228622A patent/AU2021228622A1/en active Pending
- 2021-02-23 WO PCT/US2021/019181 patent/WO2021173523A1/en not_active Ceased
- 2021-02-23 EP EP21712350.4A patent/EP4110298A1/en active Pending
- 2021-02-23 CN CN202180016511.0A patent/CN115484933B/zh active Active
- 2021-02-23 MX MX2022010410A patent/MX2022010410A/es unknown
- 2021-02-23 US US17/798,904 patent/US20230295183A1/en active Pending